Mitochondrial DNA Copy Number in Cervical Exfoliated Cells and Risk of Cervical Cancer Among HPV-positive Women

Overview

Journal BMC Womens Health

Publisher Biomed Central

Specialty Gynecology & Obstetrics

Date 2020 Jul 4

PMID 32615963

Citations 7

Authors

Wei Sun

Xueyun Qin

Jing Zhou

Mingjing Xu

Zhangyan Lyu

Xin Li

Kai Zhang

Min Dai

Ni Li

Dong Hang

Affiliations

Soon will be listed here.

Abstract

Background: Although human papillomavirus (HPV) infection has been regarded as the cause of cervical cancer in over 99% of cases, only a small fraction of HPV-infected women develop this malignancy. Emerging evidence suggests that alterations of mitochondrial DNA copy number (mtCN) may contribute to carcinogenesis. However, the relationship between mtCN and cervical cancer remains undetermined.

Methods: The current study included 591 cervical cancer cases and 373 cancer-free controls, all of whom were infected with high-risk HPV. Relative mtCN in cervical cancer exfoliated cells was measured by qRT-PCR assays, and logistic regression analysis was performed to compute odds ratios (ORs) and 95% confidence intervals (CIs). Interaction between mtCN and HPV types was assessed by using the Wald test in logistic regression models.

Results: HPV16, 18, 52, and 58 were the most common types in both case and control groups. Median mtCN in cases was significantly higher than that in controls (1.63 vs. 1.23, P = 0.03). After adjustment for age and HPV types, the highest quartile of mtCN was associated with increased odds of having cervical cancer (OR = 1.77, 95% CI = 1.19, 2.62; P < 0.01), as compared to the lowest quartile. A dose-response effect of mtCN on cervical cancer was also observed (P < 0.001). The interaction between mtCN and HPV types was statistically nonsignificant.

Conclusions: In women who test HPV positive, the increase of mtCN in cervical exfoliated cells is associated with cervical cancer. This suggests a potential role of mtCN in cervical carcinogenesis.

Citing Articles

Mitochondrial protein isoleucyl-tRNA synthetase 2 in tumor cells as a potential therapeutic target for cervical cancer.

Meng X, Gao B, Li N Cytojournal. 2024; 21:22.

PMID: 38989294 PMC: 11234349. DOI: 10.25259/Cytojournal_17_2024.

Dyslipidemia: prevalence and association with precancerous and cancerous lesions of the cervix; a pilot study.

Mwangi G, Niyonzima N, Atwine R, Tusubira D, Mugyenyi G, Ssedyabane F Lipids Health Dis. 2024; 23(1):3.

PMID: 38184564 PMC: 10770978. DOI: 10.1186/s12944-023-01997-8.

Altered mitochondrial DNA copy number in cervical exfoliated cells among high‑risk HPV‑positive and HPV‑negative women.

Al-Awadhi R, AlRoomy M, Al-Waheeb S, Alwehaidah M Exp Ther Med. 2023; 26(5):521.

PMID: 37854504 PMC: 10580246. DOI: 10.3892/etm.2023.12220.

BRSK1 confers cisplatin resistance in cervical cancer cells via regulation of mitochondrial respiration.

Liu G, Li L, Shang D, Zhou C, Zhang C J Cancer Res Clin Oncol. 2023; 149(11):8803-8815.

PMID: 37140697 DOI: 10.1007/s00432-023-04821-z.

Targeting Mitochondrial Therapy in the Regulation of HPV Infection and HPV-Related Cancers.

Cruz-Gregorio A, Aranda-Rivera A, Roviello G, Pedraza-Chaverri J Pathogens. 2023; 12(3).

PMID: 36986324 PMC: 10054155. DOI: 10.3390/pathogens12030402.

References

Kabekkodu S, Bhat S, Mascarenhas R, Mallya S, Bhat M, Pandey D . Mitochondrial DNA variation analysis in cervical cancer. Mitochondrion. 2013; 16:73-82. DOI: 10.1016/j.mito.2013.07.001. View

Gustinucci D, Rossi P, Cesarini E, Broccolini M, Bulletti S, Carlani A . Use of Cytology, E6/E7 mRNA, and p16INK4a-Ki-67 to Define the Management of Human Papillomavirus (HPV)-Positive Women in Cervical Cancer Screening. Am J Clin Pathol. 2015; 145(1):35-45. DOI: 10.1093/ajcp/aqv019. View

Warowicka A, Kwasniewska A, Gozdzicka-Jozefiak A . Alterations in mtDNA: a qualitative and quantitative study associated with cervical cancer development. Gynecol Oncol. 2013; 129(1):193-8. DOI: 10.1016/j.ygyno.2013.01.001. View

Tornesello M, Buonaguro L, Giorgi-Rossi P, Buonaguro F . Viral and cellular biomarkers in the diagnosis of cervical intraepithelial neoplasia and cancer. Biomed Res Int. 2014; 2013:519619. PMC: 3872027. DOI: 10.1155/2013/519619. View

Zhu X, Mao Y, Huang T, Yan C, Yu F, Du J . High mitochondrial DNA copy number was associated with an increased gastric cancer risk in a Chinese population. Mol Carcinog. 2017; 56(12):2593-2600. DOI: 10.1002/mc.22703. View

Bloem P, Ogbuanu I . Vaccination to prevent human papillomavirus infections: From promise to practice. PLoS Med. 2017; 14(6):e1002325. PMC: 5486966. DOI: 10.1371/journal.pmed.1002325. View

Hu L, Yao X, Shen Y . Altered mitochondrial DNA copy number contributes to human cancer risk: evidence from an updated meta-analysis. Sci Rep. 2016; 6:35859. PMC: 5075889. DOI: 10.1038/srep35859. View

Lai D, Tan C, Gunaratne J, Quek L, Nei W, Thierry F . Localization of HPV-18 E2 at mitochondrial membranes induces ROS release and modulates host cell metabolism. PLoS One. 2013; 8(9):e75625. PMC: 3782431. DOI: 10.1371/journal.pone.0075625. View

Coquillard G, Palao B, Patterson B . Quantification of intracellular HPV E6/E7 mRNA expression increases the specificity and positive predictive value of cervical cancer screening compared to HPV DNA. Gynecol Oncol. 2010; 120(1):89-93. DOI: 10.1016/j.ygyno.2010.09.013. View

10.

Marullo R, Werner E, Zhang H, Chen G, Shin D, Doetsch P . HPV16 E6 and E7 proteins induce a chronic oxidative stress response via NOX2 that causes genomic instability and increased susceptibility to DNA damage in head and neck cancer cells. Carcinogenesis. 2015; 36(11):1397-406. PMC: 4751247. DOI: 10.1093/carcin/bgv126. View

11.

Williams V, Filippova M, Filippov V, Payne K, Duerksen-Hughes P . Human papillomavirus type 16 E6* induces oxidative stress and DNA damage. J Virol. 2014; 88(12):6751-61. PMC: 4054338. DOI: 10.1128/JVI.03355-13. View

12.

Lu J, Sharma L, Bai Y . Implications of mitochondrial DNA mutations and mitochondrial dysfunction in tumorigenesis. Cell Res. 2009; 19(7):802-15. PMC: 4710094. DOI: 10.1038/cr.2009.69. View

13.

Matoba S, Kang J, Patino W, Wragg A, Boehm M, Gavrilova O . p53 regulates mitochondrial respiration. Science. 2006; 312(5780):1650-3. DOI: 10.1126/science.1126863. View

14.

Wang Y, Liu V, Xue W, Tsang P, Cheung A, Ngan H . The increase of mitochondrial DNA content in endometrial adenocarcinoma cells: a quantitative study using laser-captured microdissected tissues. Gynecol Oncol. 2005; 98(1):104-10. DOI: 10.1016/j.ygyno.2005.04.015. View

15.

Arbyn M, Raifu A, Weiderpass E, Bray F, Anttila A . Trends of cervical cancer mortality in the member states of the European Union. Eur J Cancer. 2009; 45(15):2640-8. DOI: 10.1016/j.ejca.2009.07.018. View

16.

Lee H, Li S, Lin J, Wu C, Yeh D, Wei Y . Somatic mutations in the D-loop and decrease in the copy number of mitochondrial DNA in human hepatocellular carcinoma. Mutat Res. 2004; 547(1-2):71-8. DOI: 10.1016/j.mrfmmm.2003.12.011. View

17.

Kulawiec M, Ayyasamy V, Singh K . p53 regulates mtDNA copy number and mitocheckpoint pathway. J Carcinog. 2009; 8:8. PMC: 2687143. DOI: 10.4103/1477-3163.50893. View

18.

Safdar A, Khrapko K, Flynn J, Saleem A, DE Lisio M, Johnston A . Exercise-induced mitochondrial p53 repairs mtDNA mutations in mutator mice. Skelet Muscle. 2016; 6:7. PMC: 4733510. DOI: 10.1186/s13395-016-0075-9. View

19.

Scheffner M, Huibregtse J, Vierstra R, Howley P . The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell. 1993; 75(3):495-505. DOI: 10.1016/0092-8674(93)90384-3. View

20.

Picard M, Wallace D, Burelle Y . The rise of mitochondria in medicine. Mitochondrion. 2016; 30:105-16. PMC: 5023480. DOI: 10.1016/j.mito.2016.07.003. View